2fc6e40b的个人主页 - 老虎社区

2fc6e40b

暂无个人介绍

IP属地：广东

0关注

0粉丝

1主题

0勋章

2022-08-30

可惜

抱歉，原内容已删除

去老虎APP查看更多动态

{"i18n":{"language":"zh_CN"},"userPageInfo":{"id":3552187859584454,"uuid":"3552187859584454","gmtCreate":1589094964543,"gmtModify":1600176526544,"name":"2fc6e40b","pinyin":"nksnbjjningkeshinianbujiangjun","introduction":"","introductionEn":"","signature":"","avatar":"https://community-static.tradeup.com/news/default-avatar.jpg","hat":null,"hatId":null,"hatName":null,"vip":1,"status":2,"fanSize":0,"headSize":0,"tweetSize":1,"questionSize":0,"limitLevel":100,"accountStatus":3,"level":{"id":2,"name":"无畏虎","nameTw":"無畏虎","represent":"初生牛犊","factor":"发布3条非转发主帖,1条获得他人回复或点赞","iconColor":"3C9E83","bgColor":"A2F1D9"},"themeCounts":1,"badgeCounts":0,"badges":[],"moderator":false,"superModerator":false,"manageSymbols":null,"badgeLevel":null,"boolIsFan":false,"boolIsHead":false,"favoriteSize":1,"symbols":null,"coverImage":null,"realNameVerified":null,"userBadges":[{"badgeId":"e50ce593bb40487ebfb542ca54f6a561-3","templateUuid":"e50ce593bb40487ebfb542ca54f6a561","name":"偶像虎友","description":"加入老虎社区1500天","bigImgUrl":"https://static.tigerbbs.com/8b40ae7da5bf081a1c84df14bf9e6367","smallImgUrl":"https://static.tigerbbs.com/f160eceddd7c284a8e1136557615cfad","grayImgUrl":"https://static.tigerbbs.com/11792805c468334a9b31c39f95a41c6a","redirectLinkEnabled":0,"redirectLink":null,"hasAllocated":1,"isWearing":0,"stamp":null,"stampPosition":0,"hasStamp":0,"allocationCount":1,"allocatedDate":"2024.06.19","exceedPercentage":null,"individualDisplayEnabled":0,"backgroundColor":null,"fontColor":null,"individualDisplaySort":0,"categoryType":1001}],"userBadgeCount":1,"currentWearingBadge":null,"individualDisplayBadges":null,"crmLevel":1,"crmLevelSwitch":0,"location":"广东","starInvestorFollowerNum":0,"starInvestorFlag":false,"starInvestorOrderShareNum":0,"subscribeStarInvestorNum":0,"ror":null,"winRationPercentage":null,"showRor":false,"investmentPhilosophy":null,"starInvestorSubscribeFlag":false},"baikeInfo":{},"tab":"post","tweets":[{"id":660521795,"gmtCreate":1661832697118,"gmtModify":1661832697118,"author":{"id":"3552187859584454","authorId":"3552187859584454","name":"2fc6e40b","avatar":"https://community-static.tradeup.com/news/default-avatar.jpg","crmLevel":1,"crmLevelSwitch":0,"followedFlag":false},"themes":[],"htmlText":"可惜","listText":"可惜","text":"可惜","images":[],"top":1,"highlighted":1,"essential":1,"paper":1,"likeSize":0,"commentSize":0,"repostSize":0,"link":"https://laohu8.com/post/660521795","repostId":"2263172015","repostType":2,"isVote":1,"tweetType":1,"viewCount":602,"authorTweetTopStatus":1,"verified":2,"comments":[],"imageCount":0,"langContent":"CN","totalScore":0}],"hots":[{"id":660521795,"gmtCreate":1661832697118,"gmtModify":1661832697118,"author":{"id":"3552187859584454","authorId":"3552187859584454","name":"2fc6e40b","avatar":"https://community-static.tradeup.com/news/default-avatar.jpg","crmLevel":1,"crmLevelSwitch":0,"followedFlag":false},"themes":[],"htmlText":"可惜","listText":"可惜","text":"可惜","images":[],"top":1,"highlighted":1,"essential":1,"paper":1,"likeSize":0,"commentSize":0,"repostSize":0,"link":"https://laohu8.com/post/660521795","repostId":"2263172015","repostType":2,"repost":{"id":"2263172015","pubTimestamp":1661776500,"share":"https://www.laohu8.com/m/news/2263172015?lang=&edition=full","pubTime":"2022-08-29 20:35","market":"hk","language":"zh","title":"复星医药：所持BNTX股票股价变动致公允价值损失等净影响超10亿 上半年归母净利润同比下降37.67%","url":"https://stock-news.laohu8.com/highlight/detail?id=2263172015","media":"界面新闻","summary":"复星医药8月29日公告称，公司上半年实现营业收入213.4亿元，同比上涨25.88%；归母净利润15.47亿元，同比下降37.67%；因所持BNTX股票股价变动致公允价值损失等净影响10亿余元，扣非后...","content":"<div>\n<p>复星医药8月29日公告称，公司上半年实现营业收入213.4亿元，同比上涨25.88%；归母净利润15.47亿元，同比下降37.67%；因所持BNTX股票股价变动致公允价值损失等净影响10亿余元，扣非后业绩增长18.57%。得益于新产品和抗疫产品的收入贡献以及营销费用的有效控制，报告期内，集团营业收入和经常性收益继续保持稳健增长。（文章来源：界面新闻）</p>\n\n<a href=\"http://finance.eastmoney.com/a/202208292494306169.html\">Web Link</a>\n\n</div>\n","source":"stock_eastmoney","collect":0,"html":"<!DOCTYPE html>\n<html>\n<head>\n<meta http-equiv=\"Content-Type\" content=\"text/html; charset=utf-8\" />\n<meta name=\"viewport\" content=\"width=device-width,initial-scale=1.0,minimum-scale=1.0,maximum-scale=1.0,user-scalable=no\"/>\n<meta name=\"format-detection\" content=\"telephone=no,email=no,address=no\" />\n<title>复星医药：所持BNTX股票股价变动致公允价值损失等净影响超10亿 上半年归母净利润同比下降37.67%</title>\n<style type=\"text/css\">\na,abbr,acronym,address,applet,article,aside,audio,b,big,blockquote,body,canvas,caption,center,cite,code,dd,del,details,dfn,div,dl,dt,\nem,embed,fieldset,figcaption,figure,footer,form,h1,h2,h3,h4,h5,h6,header,hgroup,html,i,iframe,img,ins,kbd,label,legend,li,mark,menu,nav,\nobject,ol,output,p,pre,q,ruby,s,samp,section,small,span,strike,strong,sub,summary,sup,table,tbody,td,tfoot,th,thead,time,tr,tt,u,ul,var,video{ font:inherit;margin:0;padding:0;vertical-align:baseline;border:0 }\nbody{ font-size:16px; line-height:1.5; color:#999; background:transparent; }\n.wrapper{ overflow:hidden;word-break:break-all;padding:10px; }\nh1,h2{ font-weight:normal; line-height:1.35; margin-bottom:.6em; }\nh3,h4,h5,h6{ line-height:1.35; margin-bottom:1em; }\nh1{ font-size:24px; }\nh2{ font-size:20px; }\nh3{ font-size:18px; }\nh4{ font-size:16px; }\nh5{ font-size:14px; }\nh6{ font-size:12px; }\np,ul,ol,blockquote,dl,table{ margin:1.2em 0; }\nul,ol{ margin-left:2em; }\nul{ list-style:disc; }\nol{ list-style:decimal; }\nli,li p{ margin:10px 0;}\nimg{ max-width:100%;display:block;margin:0 auto 1em; }\nblockquote{ color:#B5B2B1; border-left:3px solid #aaa; padding:1em; }\nstrong,b{font-weight:bold;}\nem,i{font-style:italic;}\ntable{ width:100%;border-collapse:collapse;border-spacing:1px;margin:1em 0;font-size:.9em; }\nth,td{ padding:5px;text-align:left;border:1px solid #aaa; }\nth{ font-weight:bold;background:#5d5d5d; }\n.symbol-link{font-weight:bold;}\n/* header{ border-bottom:1px solid #494756; } */\n.title{ margin:0 0 8px;line-height:1.3;color:#ddd; }\n.meta {color:#5e5c6d;font-size:13px;margin:0 0 .5em; }\na{text-decoration:none; color:#2a4b87;}\n.meta .head { display: inline-block; overflow: hidden}\n.head .h-thumb { width: 30px; height: 30px; margin: 0; padding: 0; border-radius: 50%; float: left;}\n.head .h-content { margin: 0; padding: 0 0 0 9px; float: left;}\n.head .h-name {font-size: 13px; color: #eee; margin: 0;}\n.head .h-time {font-size: 11px; color: #7E829C; margin: 0;line-height: 11px;}\n.small {font-size: 12.5px; display: inline-block; transform: scale(0.9); -webkit-transform: scale(0.9); transform-origin: left; -webkit-transform-origin: left;}\n.smaller {font-size: 12.5px; display: inline-block; transform: scale(0.8); -webkit-transform: scale(0.8); transform-origin: left; -webkit-transform-origin: left;}\n.bt-text {font-size: 12px;margin: 1.5em 0 0 0}\n.bt-text p {margin: 0}\n</style>\n</head>\n<body>\n<div class=\"wrapper\">\n<header>\n<h2 class=\"title\">\n复星医药：所持BNTX股票股价变动致公允价值损失等净影响超10亿 上半年归母净利润同比下降37.67%\n</h2>\n\n<h4 class=\"meta\">\n\n\n2022-08-29 20:35 北京时间&nbsp;&nbsp;&nbsp;<a href=http://finance.eastmoney.com/a/202208292494306169.html><strong>界面新闻</strong></a>\n\n\n</h4>\n\n</header>\n<article>\n<div>\n<p>复星医药8月29日公告称，公司上半年实现营业收入213.4亿元，同比上涨25.88%；归母净利润15.47亿元，同比下降37.67%；因所持BNTX股票股价变动致公允价值损失等净影响10亿余元，扣非后业绩增长18.57%。得益于新产品和抗疫产品的收入贡献以及营销费用的有效控制，报告期内，集团营业收入和经常性收益继续保持稳健增长。（文章来源：界面新闻）</p>\n\n<a href=\"http://finance.eastmoney.com/a/202208292494306169.html\">Web Link</a>\n\n</div>\n\n\n</article>\n</div>\n</body>\n</html>\n","type":0,"thumbnail":"","relate_stocks":{"02196":"复星医药","BNTX":"BioNTech SE"},"source_url":"http://finance.eastmoney.com/a/202208292494306169.html","is_english":false,"share_image_url":"https://static.laohu8.com/e9f99090a1c2ed51c021029395664489","article_id":"2263172015","content_text":"复星医药8月29日公告称，公司上半年实现营业收入213.4亿元，同比上涨25.88%；归母净利润15.47亿元，同比下降37.67%；因所持BNTX股票股价变动致公允价值损失等净影响10亿余元，扣非后业绩增长18.57%。得益于新产品和抗疫产品的收入贡献以及营销费用的有效控制，报告期内，集团营业收入和经常性收益继续保持稳健增长。（文章来源：界面新闻）","news_type":1},"isVote":1,"tweetType":1,"viewCount":602,"authorTweetTopStatus":1,"verified":2,"comments":[],"imageCount":0,"langContent":"CN","totalScore":0}],"lives":[]}